The Editor-in Chief for DHR Proceedings weights on the decision to stop the administration of the Johnson and Johnson Jansen's COvid-19 vaccine.
Full Issue
Editorial
Is the Public Outcry for Johnson & Johnson Jansen’s COVID-19 Vaccine Causing Blood Clots Justified?
Abstract 110 | PDF Downloads 143 | DOI https://doi.org/10.47488/dhrp.v1iS2.12Page 1-2